Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001003460) titled 'ALLG AMLM29 CAVIAT-R (Chemotherapy and Venetoclax in Acute Myeloid Leukaemia (AML) Trial- Randomised): a multicentre phase III trial investigating venetoclax plus intensive chemotherapy for newly diagnosed AML' on Sept. 10.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Australasian Leukaemia and Lymphoma Group
Condition:
Acute Myeloid Leukaemia
Acute Myeloid Leukaemia
Cancer - Leukaemia - Acute leukaemia
Intervention:
The intervention is Venetoclax in combination with a reduced intensive chemotherapy regimen in induction and consoli...